The emerging interdisciplinary field, mechanobiology, is focused on understanding how cells sense their surroundings and transfer biomechanical signals to initiate cellular changes. I aim to develop hydrogel platforms with differential stiffness patterns to study cellular mechanotransduction and to generate heart muscle cells. The findings have the potential to greatly improve the clinical outcomes where more than 10 clinical trials failed to show successful regeneration after heart attack.
Platform Nanotechnologies For Oral Delivery Of Drugs, Therapeutic Protein And Peptide Delivery
Funder
National Health and Medical Research Council
Funding Amount
$437,034.00
Summary
The development of reliable oral delivery systems for problem drugs and biologics is one of the biggest challenges faced by the pharmaceutical industry in recent times. In order to tackle these challenges, I have developed programmable nanoparticles capable of efficiently deliver wide range of drugs including large peptides and proteins orally.
If stem cell transplantation is to be useful to repair brain injury, advancement must be made to improve the delivery, survival and differentiation of transplanted cells so that they can sufficiently integrate into the host brain. Here, self-assembling peptides will be developed to provide physical and biochemical support for stem cells and neurones in cell culture (which may be useful for drug discovery) and following transplantation into the injured brain.